The Global Impact of Respiratory Syncytial Virus in the Era of Emerging Infectious Diseases
*Corresponding Author:Received Date: May 01, 2024 / Published Date: May 29, 2024
Citation: Prasad B (2024) The Global Impact of Respiratory Syncytial Virus in the Era of Emerging Infectious Diseases. J Clin Infect Dis Pract 9: 243.DOI: 10.4172/2476-213X.1000243
Copyright: 漏 2024 Prasad B. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Respiratory Syncytial Virus (RSV) poses a substantial threat to global health, particularly affecting infants, young children, and older adults, leading to respiratory illnesses of varying severity. This article offers a comprehensive exploration of RSV, covering its epidemiology, clinical manifestations, diagnostic methods, treatment options, and preventive measures. Furthermore, it delves into ongoing research endeavors focused on unravelling the intricate pathogenesis of the virus, while concurrently striving to pioneer novel vaccines and antiviral therapies. By synthesizing current knowledge with evolving research insights, this article aims to contribute to the collective effort in combating RSV and improving public health outcomes worldwide.
